Clinical trial

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung…

NCT00031785 · Wake Forest University Health Sciences, Other · Completed

Key facts

NCT number NCT00031785
Title Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Official title A Phase III, Double-Blind, Randomized Study of the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Lung Cancer Patients Receiving Thoracic Radiation Therapy
Lead sponsor Wake Forest University Health Sciences, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Anorexia, Cachexia, Lung Cancer
Intervention type Drug, Radiation
Interventions megestrol acetate, radiation therapy
Enrollment 25
Start date Sep 1, 2000
Primary completion Sep 11, 2002
Completion Sep 11, 2002
First posted Aug 6, 2003
Last update posted Sep 9, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies